Evidence map›Paper›PMID 36113105›Full record

ArticlePublic health reports (Washington, D.C. : 1974)

Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021.

Don C Des Jarlais, Czarina N Behrends, Maria A Corcorran, Sara N Glick, David C Perlman, Shashi N Kapadia, Xinlin Lu, Jonathan Feelemyer, Paul LaKosky, Stephanie M Prohaska and 1 more

Open access · greenAbstract read
In one paragraph

Article in Public health reports (Washington, D.C. : 1974). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Don C Des JarlaisSchool of Global Public Health, New York University, New York, NY, USA.ORCID 0000-0002-0157-8168
Czarina N BehrendsDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Maria A CorcorranDivision of Allergy and Infectious Diseases, School of Medicine, University of Washington, Seattle, WA, USA.
Sara N GlickDivision of Allergy and Infectious Diseases, School of Medicine, University of Washington, Seattle, WA, USA.
David C PerlmanDivision of Infectious Diseases, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Shashi N KapadiaDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Xinlin LuSchool of Global Public Health, New York University, New York, NY, USA.
Jonathan FeelemyerSchool of Global Public Health, New York University, New York, NY, USA.
Paul LaKoskyNorth American Syringe Exchange Network, Tacoma, WA, USA.
Stephanie M ProhaskaNorth American Syringe Exchange Network, Tacoma, WA, USA.
Bruce R SchackmanDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Cornell University · USNew York University · USScience Exchange (United States) · USUniversity of Washington · USMount Sinai Beth Israel · US

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI LINDA M COLLINS · 1998 to 2026
$38.9M
Utilization of health services after engagement with opioid use disorder (OUD) treatment provider by individuals with and without post-traumatic stress disorderP30DA040500 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Benjamin P. Linas · 2015 to 2026
$20.7M
Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment ProgramsR01DA027379 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI SCHACKMAN, BRUCE R · 2009 to 2021
$5.3M
Integrated Care for Hepatitis C: Current Uptake & Impact on Future TreatmentK01DA048172 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI KAPADIA, SHASHI · 2019 to 2023
$948k
NIDA NIH HHS K01 DA048172NIDA NIH HHS P30 DA011041NIDA NIH HHS P30 DA040500NIDA NIH HHS R01 DA027379
6 · The paper itself

Abstract

Many syringe services programs (SSPs) have established trusting, long-term relationships with their clients and are well situated to provide COVID-19 vaccinations. We examined characteristics and practices of SSPs in the United States that reported providing COVID-19 vaccinations to their clients and obstacles to vaccinating people who inject drugs (PWID). We surveyed SSPs in September 2021 to examine COVID-19 vaccination practices through a supplement to the 2020 Dave Purchase Memorial survey. Of 153 SSPs surveyed, 73 (47.7%) responded to the supplement; 24 of 73 (32.9%) reported providing on-site COVID-19 vaccinations. Having provided hepatitis and influenza vaccinations was significantly associated with providing COVID-19 vaccinations (70.8% had provided them vs 28.6% had not;

Indexed as

COVID-19HIV InfectionsSubstance Abuse, IntravenousCOVID-19 VaccinesHumansNeedle-Exchange ProgramsSyringesUnited StatesVaccinationCOVID-19 VaccinesCOVID-19hepatitis CHIVsyringe services programsvaccination

Identifiers

PMID36113105
PMCPMC9574299
OpenAlexW4296042357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.